Kimmel P L, Weihs K, Peterson R A
Department of Medicine, George Washington University Medical Center, Washington, D.C. 20037.
J Am Soc Nephrol. 1993 Jul;4(1):12-27. doi: 10.1681/ASN.V4112.
Depression has been identified at the most prevalent psychologic problem in patients with ESRD treated with hemodialysis (HD). Depression has been associated with mortality in HD patients; however, the similarity of the symptoms of depressive disorders to those of uremia and the difficulties in measuring depression and dissociating psychologic from physical aspects of depression in such patients render these studies difficult to evaluate. Conflicting data regarding the effects of depression on survival in HD patients may be the result of using somatic symptoms in quantifying the extent of depression. In this review, studies regarding the diagnosis of depression in HD patients, the association of depression and survival in HD patients in light of recent work on factors related to the morbidity and mortality in the ESRD population, and aspects of therapy for depression in HD patients are considered. Specifically, depression may affect immunologic function, nutrition, and compliance factors that may affect the prescription and delivery of dialysis, which may, in turn, influence outcome. Alternatively, depression may be an independent factor in influencing survival. Cognitive depression measures may be more useful in predicting outcome in HD patients than standard measures used in nonmedically ill populations. Although there are few studies of the effect of treatment of depression on outcome in HD patients, it is reasonable to hypothesize that treatment of depressive disorders in HD patients might effect outcome. Further studies on the association of depression and its treatment and mortality in ESRD patients are warranted.
抑郁症已被确定为接受血液透析(HD)治疗的终末期肾病(ESRD)患者中最普遍的心理问题。抑郁症与HD患者的死亡率相关;然而,抑郁症的症状与尿毒症的症状相似,且在此类患者中测量抑郁症以及区分抑郁症的心理方面与身体方面存在困难,这使得这些研究难以评估。关于抑郁症对HD患者生存影响的相互矛盾的数据,可能是由于在量化抑郁症程度时使用了躯体症状。在本综述中,我们考虑了关于HD患者抑郁症诊断的研究、鉴于近期有关ESRD人群发病率和死亡率相关因素的研究,抑郁症与HD患者生存的关联,以及HD患者抑郁症治疗的各个方面。具体而言,抑郁症可能会影响免疫功能、营养和依从性因素,这些因素可能会影响透析的处方和实施,进而可能影响治疗结果。或者,抑郁症可能是影响生存的一个独立因素。认知性抑郁症测量方法在预测HD患者的治疗结果方面可能比用于非疾病人群的标准测量方法更有用。尽管关于抑郁症治疗对HD患者治疗结果影响的研究很少,但有理由假设HD患者抑郁症的治疗可能会影响治疗结果。有必要进一步研究ESRD患者中抑郁症及其治疗与死亡率之间的关联。